4Elliot WJ, Plausechinat CA, Skrepnek GH, et al. Persistence,adherence,and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Med,2007,20:72
5Kjeldsen SE, Julius S, Mancia G, et al. Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high risk hypertensive patients: the VALUE trial. J Hypertens, 2006,24 : 1405
6Pool JL, Glazer R, Weinberger M, et al. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Clin Ther,2007 ,29 :61
3Chobanian AV,Bakris GL,Black HR,et al.National Heart,Lung,and Blood Institute:Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating committee.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure:the JNC 7 report.JAMA 2003; 289(19):2560-2572.
4Cifkova R,Erdine S,Fagard R,et al.ESH/ESC Hypertension Guidelines Committee.Practice guidelines for primary care physicians:2003 ESH/ESC hypertension guidelines.J Hypertens 2003; 21(10):1779-1786.
5Williams B,Poulter NR,Brown MJ,et al.British Hypertension Society.Guidelines for management of hypertension:report of the fourth working party of the British Hypertension Society,2004-BHS Ⅳ.J Hum Hypertens 2004; 18(3):139-185.
